Company Filing History:
Years Active: 2020
Title: Fayez O Alotaibi: Innovator in Pharmaceutical Formulations
Introduction
Fayez O Alotaibi is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of medications for male sexual dysfunction.
Latest Patents
Fayez O Alotaibi holds a patent for a liquisolid tablet containing a combined dose of tadalafil and dapoxetine. This liquisolid tablet formulation comprises a microcrystalline cellulose carrier, a silica coating, and a crosslinked polyvinylpyrrolidone (PVP) superdisintegrant. The solvent used in the formulation includes polyethylene glycol (PEG) 200 and caprylocaproyl macrogol-8 glycerides. The patent specifies that the liquid load factor of the formulation is between 0.2 and 0.4. Additionally, methods for making the liquisolid tablet and using the formulation for treating male sexual dysfunction are also provided.
Career Highlights
Fayez O Alotaibi is affiliated with King Abdulaziz University, where he contributes to research and development in pharmaceutical sciences. His innovative approach to drug formulation has garnered attention in the academic and medical communities.
Collaborations
Fayez has collaborated with notable colleagues, including Khalid Mohamed El-Say and Nabil Abdulhafiz Alhakamy. Their joint efforts have further advanced research in the field of pharmaceutical formulations.
Conclusion
Fayez O Alotaibi's contributions to the development of liquisolid tablet formulations represent a significant advancement in the treatment of male sexual dysfunction. His innovative work continues to impact the pharmaceutical industry positively.